Skip to content

Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

Prospective Clinical Study on Postoperative Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02020044
Enrollment
200
Registered
2013-12-24
Start date
2012-09-30
Completion date
Unknown
Last updated
2013-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fuchs' Endothelial Corneal Dystrophy, Bullous Keratopathy, Iridocorneal Endothelial Syndrome, Posterior Polymorphous Dystrophy, Endothelial Dysfunction

Brief summary

The purpose of this study is evaluate the outcome after posterior lamellar keratoplasty (DMEK and Ultra-thin DSAEK) for corneal transplantation.

Interventions

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female aged 18 or older * Scheduled to undergo endothelial keratoplasty * Able to provide written informed consent.

Exclusion criteria

* Age less than 18 years

Design outcomes

Primary

MeasureTime frame
Visual acuity (change from baseline)1, 3, 6, and 12 months and annually

Secondary

MeasureTime frameDescription
Intraocular pressure (change from baseline)1, 3, 6, and 12 months and annually
Manifest refraction (change from baseline)1, 3, 6, 12 months and annually
corneal pachymetry (change from baseline)1, 3, 6, 12 months and annually
Quality of Life, NEI-VFQ 25 (change from baseline)3, 12 months, annualyQuestionnaire
Endothelial cell density (change from baseline)1, 3, 6, and 12 months and annually
Anterior Segment OCT of cornea and anterior chamber angle (change from baseline)1, 3, 6, and 12 months and annually
postoperative Medication (change from baseline)1,3,6 and 12 months and annually
Histological Sample of Recipient's Descemet MembraneintraoperativeRecipient's Descemet Membrane
corneal topography (change from baseline)1, 3, 6, and 12 months and annually

Countries

Germany

Contacts

Primary ContactAnna-Karina Maier, MD
anna-karina.maier@charite.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026